UMIN000052408
A prospective observational study to assess the utility of comprehensive genomic profiling in patients with non-small cell lung cancer without driver genetic alterations
A prospective observational study to assess the utility of comprehensive genomic profiling in patients with non-small cell lung cancer without driver genetic alterations identified by multiplex companion diagnostics
Hamamatsu University School of Medicine·University Hospital Medical Information NetworkRecruiting
Study focus
- Disease/Condition
- Non-small cell lung cancer
- Study type
- Observational
Sponsor & location
- Primary sponsor
- Hamamatsu University School of Medicine
- Location
- Japan
Timeline & enrollment
- Phase
- N/A
- Start date
- Oct 10, 2023
- End date
- N/A
ICD-10 classifications
Secondary malignant neoplasm of lungMalignant neoplasm: Lower lobe, bronchus or lungMalignant neoplasm: Middle lobe, bronchus or lungMalignant neoplasm: Bronchus or lung, unspecifiedMalignant neoplasm of bronchus and lung
Data source
- Registry
- University Hospital Medical Information Network
- Trial ID
- UMIN000052408
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for UMIN000052408 through Pure Global AI's free database. This phase not specified trial is sponsored by Hamamatsu University School of Medicine and is currently Recruiting. The study focuses on Non-small cell lung cancer.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to University Hospital Medical Information Network data, helping medical device and pharmaceutical companies navigate clinical research efficiently.